Announcements
Sidley Advises PhaseV in Its US$50 Million Series A Financing
May 14, 2025
Sidley advised PhaseV Trials Inc., a leader in AI/ML-driven clinical development, in its US$50 million Series A financing round. The round was co-led by Accel and Insight Partners, with participation from Viola Ventures, Exor Ventures, and LionBird.
For additional information, please refer to the press release.
The Sidley team was led by Dr. Idan Netser and Jake Funk (Emerging Companies and Venture Capital).
Contacts
Capabilities
Suggested News & Insights
Sidley Represents FormX in Its US$12.5 Million Series Seed FinancingAugust 11, 2026Sidley Represents Sapiom in US$35 Million Series A FinancingAugust 5, 2026Sidley Represents CAIS in Its US$170 Million Series D FinancingJuly 29, 2026Sidley Represents Jane Street in Its Investments in AI Chip Maker EtchedJuly 27, 2026Sidley Represents Elio in US$21 Million Series A FinancingJuly 23, 2026Sidley Adds Mayan Katz to Emerging Companies and Venture Capital and Global Life Sciences Practices in New YorkJuly 8, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory